文章基本信息

标题：Rapamycin extends life- and health span because it slows aging
本地全文：下载
作者：Mikhail V. Blagosklonny
期刊名称：Aging
出版年度：2013
卷号：5
期号：8
页码：592-598
出版社：U.S.Department of Health & Human Service
摘要：
Making headlines, a thought-provocative paper by Neff, Ehninger and coworkers claims that rapamycin extends life span but has limited effects on aging. How is that possibly possible? And what is aging if not an increase of the probability of death with age. I discuss that the JCI paper actually shows that rapamycin slows aging and also extends lifespan regardless of its direct anti-cancer activities. Aging is, in part, MTOR-driven: a purposeless continuation of developmental growth. Rapamycin affects the same processes in young and old animals: young animals' traits and phenotypes, which continuations become hyperfunctional, harmful and lethal later in life.
-->SOME HEADER NAME-->Quisque ante ipsum, ullamcorper vel, eleifend sed, molestie sed, est. In scelerisque, elit semper ornare hendrerit, nisi nulla commodo sem,
-->Quisque ante ipsum, ullamcorper vel, eleifend sed, molestie sed, est. In scelerisque, elit semper ornare hendrerit, nisi nulla commodo sem, Read more »
-->Quisque ante ipsum, ullamcorper vel, eleifend sed, molestie sed, est. In scelerisque, elit semper ornare hendrerit, nisi nulla commodo sem
-->-->
关键词：murine lifespan; mammalian target of rapamycin; rapalogs; diseases; age-relayed pathology